RICHARD J. BERMAN - 05 Apr 2022 Form 4 Insider Report for BIOVIE INC. (BIVI)

Role
Director
Signature
/s/ Joanne Wendy Kim as Attorney-In-Fact
Issuer symbol
BIVI
Transactions as of
05 Apr 2022
Net transactions value
$0
Form type
4
Filing time
20 Apr 2022, 16:47:04 UTC
Previous filing
19 Oct 2021
Next filing
03 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIVI Stock Option (right to buy) Award $0 +129,050 $0.000000 129,050 05 Apr 2022 Common Stock 129,050 $5.04 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options granted pursuant to the Company???s 2019 Omnibus Equity Incentive Plan.
F2 The options were 25% vested upon grant, with the remaining 75% vesting ratably over a three-year period on each anniversary of the grant date.